<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Reprod. Health</journal-id>
<journal-title>Frontiers in Reproductive Health</journal-title><abbrev-journal-title abbrev-type="pubmed">Front. Reprod. Health</abbrev-journal-title>
<issn pub-type="epub">2673-3153</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/frph.2022.1116800</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reproductive Health</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Highlights in HIV and STIs, 2021/2022</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Hogben</surname><given-names>Matthew S.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/868572/overview"/></contrib>
<contrib contrib-type="author"><name><surname>Feyissa</surname><given-names>Garumma T.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label><sup>1</sup></label><institution>Division of STD Prevention, Centers for Disease Control and Prevention</institution>, Atlanta, GA, United States</aff>
<aff id="aff2"><label><sup>2</sup></label><addr-line>Dornsife School of Public Health</addr-line>, <institution>Drexel University</institution>, Philadelphia, PA, United States</aff>
<author-notes>
<fn fn-type="edited-by"><p><bold>Edited and Reviewed by:</bold> Elizabeth Bukusi, Kenya Medical Research Institute (KEMRI), Kenya</p></fn>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Matthew Hogben <email>mhogben@cdc.gov</email></corresp>
<fn fn-type="other" id="fn001"><p><bold>Specialty Section:</bold> This article was submitted to HIV and STIs, a section of the journal Frontiers in Reproductive Health</p></fn>
</author-notes>
<pub-date pub-type="epub"><day>12</day><month>01</month><year>2023</year></pub-date>
<pub-date pub-type="collection"><year>2022</year></pub-date>
<volume>4</volume><elocation-id>1116800</elocation-id>
<history>
<date date-type="received"><day>05</day><month>12</month><year>2022</year></date>
<date date-type="accepted"><day>09</day><month>12</month><year>2022</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2023 Hogben and Feyissa.</copyright-statement>
<copyright-year>2023</copyright-year><copyright-holder>Hogben and Feyissa</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<kwd-group>
<kwd>HIV</kwd>
<kwd>STI (science</kwd>
<kwd>technology and innovation)</kwd>
<kwd>treatment</kwd>
<kwd>implementability</kwd>
<kwd>program evaluation</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/><equation-count count="0"/><ref-count count="4"/><page-count count="0"/><word-count count="0"/></counts>
</article-meta>
</front>
<body>
<sec><title/>
<p><bold>Editorial on the Research Topic</bold> <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/37579/highlights-in-hiv-and-stis-202122">Highlights in HIV and STIs, 2021/2022</ext-link></p>
<p>The collection of HIV and STI prevention and care articles in this Research Topic is drawn from three countries on two continents. Each appears on its own merit, and, as a group, they also illustrate important current attributes of current HIV/STI prevention. In this summary, we draw out these attributes as well as speak briefly about the overarching research principles these articles embody.</p>
<p>Two of the articles in this collection are centered around specimen self-collection, effectively expanding service provision and use in sexual health. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2020.561202">Pierz et al.</ext-link> ascertain the acceptability of self-sampling for cervical cancer screening among women in Limbe, Cameroon (some of whom were living with HIV). Women in this study did collect their own specimens (vaginal/cervical) in a private room onsite at a hospital. An extensive array of focus group discussions and in-depth interviews revealed concerns about pain and the ability to collect specimens. Participants in the study also spoke about the inhibiting presence of stigma related to HIV status, whether or not they were living with HIV themselves. Hence, it is critical to address stigma and discrimination in healthcare settings. The second article (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.634032">Leenen et al.</ext-link>) also gathered formative data about self-sampling, this time among men who have sex with men (MSM) in the Netherlands. The authors present an intervention mapping approach to increase self-sampling, this time outside of clinical settings, beginning with assessment data from MSM to guide the mapping process and increase patient engagement. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.634032">Leenen et al.</ext-link> frame their article around increasing opportunities to test for HIV in a resource-rich country. Despite different focus populations, different pathogens, and the substantive national differences between Cameroon and the Netherlands, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.634032">Leneen et al.</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2020.561202">Pierz et al.</ext-link> find similar issues pertaining to stigma and privacy as barriers to testing. This underscores the necessity of designing strategies to reduce stigma and discrimination for effective prevention and control of HIV/AIDS and STIs, as well as promotion and acceptance of sexual health services. For example, Feyissa et al. suggest an evidence-informed guideline to reduce stigma and discrimination in healthcare settings so that stigma reduction efforts will be sustained by making them part of the routine tasks of healthcare institutions and the professional responsibilities of healthcare workers (<xref ref-type="bibr" rid="B1">1</xref>). Both articles used a socio-ecological framework, explicitly in <ext-link ext-link-type="uri" xlink:href="https://research-topic-management-app.frontiersin.org/manage/37579/manuscript">Pierz et al.</ext-link> and implicitly in Figure&#x00A0;1 in <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.634032">Leenen et al.</ext-link>, to guide work to improve implementation through a theoretical frame.</p>
<p>Of the remaining two articles, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.568611">Slurink et al.</ext-link> used surveillance data to detect patterns in recent HIV infection, expanding the utility of specimens if not the manner of sampling. In a demonstration of the importance of sexual health clinics, the authors find a higher proportion of recent infections (27&#x0025;) in these clinics, compared to other testing sites (5&#x0025;&#x2013;15&#x0025;). For those testing in this Dutch study at least, clinics might serve as a particular resource for people at the highest risk of acquiring HIV. Given the salience of recent infection to transmission (<xref ref-type="bibr" rid="B2">2</xref>), sexual health clinics would then be central to identifying and preventing transmission in populations. The final article in this collection, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.664080">Anyanwu et al.</ext-link>, examines the relationship between herbal remedies and substance use (specifically, alcohol use and smoking tobacco) and liver function in HIV-infected patients in care in Port Harcourt, Nigeria. Both alcohol use and smoking were associated with higher liver enzyme levels, although herbal remedies used in traditional medicine were not. This analysis reminds us that care for HIV patients (the patients in this study had received antiretroviral therapy for at least one year) requires a complex and multifaceted approach.</p>
<p>Along with a theme of expanded testing coverage or expanded use of test results for public health benefit, the studies in these articles often facilitated the engagement of the focus populations in their own care or support as an initial tactic. The use of qualitative assessments in both <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2020.561202">Pierz et al.</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.634032">Leenen et al.</ext-link> are examples, as is the explicit use of assessment data as an initial guide to intervention mapping in the second study. Qualitative and quantitative assessments garner information about populations, disease epidemiology, and social environments, providing the context essential to formulating successful interventions (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>While discussing engaging focus populations, we can also draw upon the examples of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.664080">Anyanwu et al.</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2020.561202">Pierz et al.</ext-link> to note that people either living with HIV or vulnerable to contracting HIV have healthcare needs that extend beyond HIV. In fact, given that many such individuals are members of socially and economically marginalized populations, their needs are not even confined to healthcare. Many sexual health and STI/HIV prevention programs also offer linkage to social services. Finally, this linkage is not just for people; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.568611">Slurink et al.</ext-link> demonstrate with their use of specimens to ascertain recent HIV infection that patient health care needs (testing) can be linked to data to inform public health needs (prevention of transmission at the population level).</p>
<p>We conclude here with a few thoughts based on these articles about frameworks for research. This collection contains observational studies, but at least one is clearly designed for implementation work (<italic>via</italic> intervention mapping), and the remainder have clear paths from ascertainment and discovery to intervention, translation, and implementation. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/frph.2021.634032">Leenen et al.</ext-link> even measure the effects of <italic>prior</italic> translation efforts &#x2013; guideline restrictions on testing opportunities &#x2013; on barriers to prospective impact. A path from observation through intervention testing to implementation and impact is always an advantage in almost any stage of research; here, we allude to just such a model specifically incorporating prevention programs such as those in the articles we have summarized. Aral, Blanchard, and colleagues formulated an approach they named <italic>program science</italic>, in which strategic planning is combined with scientifically supported program implementation and then monitoring (<xref ref-type="bibr" rid="B4">4</xref>). This integrated approach incorporates implementation and operational research aimed at testing in &#x201C;real world&#x201D; settings, and the cyclical nature of the program drives further improvements aimed at population health impact. Any of the studies in this Research Topic would fit well as part of a program science agenda.</p>
</sec>
</body>
<back>
<sec id="s1"><title>Author contributions</title>
<p>MH drafted the editorial and GF edited the manuscript. Both authors provided critical conceptual content. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s3"><title>Author disclaimer</title>
<p>The findings and views of this work are those of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.</p>
</sec>
<sec id="s2" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s4" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feyissa</surname><given-names>GT</given-names></name><name><surname>Woldie</surname><given-names>M</given-names></name><name><surname>Munn</surname><given-names>Z</given-names></name><name><surname>Lockwood</surname><given-names>C</given-names></name></person-group>. <article-title>Exploration of facilitators and barriers to the implementation of a guideline to reduce HIV-related stigma and discrimination in the Ethiopian healthcare settings: a descriptive qualitative study</article-title>. <source>PLoS One</source>. (<year>2019</year>) <volume>14</volume>(<issue>5</issue>):<fpage>e0216887</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0216887</pub-id><pub-id pub-id-type="pmid">31083693</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>BG</given-names></name><name><surname>Roger</surname><given-names>M</given-names></name><name><surname>Routy</surname><given-names>JP</given-names></name><name><surname>Moisy</surname><given-names>D</given-names></name><name><surname>Ntemgwa</surname><given-names>M</given-names></name><name><surname>Matte</surname><given-names>C</given-names></name><etal/></person-group> <article-title>High rates of forward transmission events after acute/early HIV-1</article-title>. <source>J Infect Dis</source>. (<year>2007</year>) <volume>195</volume>:<fpage>951</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1086/512088</pub-id><pub-id pub-id-type="pmid">17330784</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krieger</surname><given-names>N</given-names></name></person-group>. <article-title>Proximal, distal, and the politics of causation: what&#x0027;s level got to do with it?</article-title> <source>Am J Public Health</source>. (<year>2008</year>) <volume>98</volume>:<fpage>221</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.2105/AJPH.2007.111278</pub-id><pub-id pub-id-type="pmid">18172144</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aral</surname><given-names>SO</given-names></name><name><surname>Blanchard</surname><given-names>JF</given-names></name></person-group>. <article-title>The program science initiative: improving the planning, implementation and evaluation of HIV/STI prevention programs</article-title>. <source>Sex Transm Inf</source>. (<year>2012</year>) <volume>88</volume>(<issue>3</issue>):<fpage>157</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/sextrans-2011-050389</pub-id></citation></ref></ref-list>
</back>
</article>